Attached files

file filename
EX-32.2 - EXHIBIT 32.2 SECTION 906 CERTIFICATIONS - Pharmagen, Inc.f10qa2063012_ex32z2.htm
EX-32.1 - EXHIBIT 32.1 SECTION 906 CERTIFICATIONS - Pharmagen, Inc.f10qa2063012_ex32z1.htm
EX-31.1 - EXHIBIT 31.1 SECTION 302 CERTIFICATIONS - Pharmagen, Inc.f10qa2063012_ex31z1.htm
EX-31.2 - EXHIBIT 31.2 SECTION 302 CERTIFICATIONS - Pharmagen, Inc.f10qa2063012_ex31z2.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549


Form 10-Q/A

Amendment No. 2


(Mark One)


  X .

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the quarterly period ended June 30, 2012


      .

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the transition period from _______________ to _______________.


Commission file number:  000-54523


SUNPEAKS VENTURES, INC.

(Exact name of registrant as specified in its charter)


Nevada

(State or other jurisdiction of

incorporation or organization)

27-0777112

(I.R.S. Employer

Identification No.)


9337 Fraser Avenue

Silver Spring, MD

(Address of principal executive offices)



20910

(Zip Code)


Registrant’s telephone number, including area code    (204) 898-8160



Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes        .  No    X  .


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes       .   No   X  .


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer        .

Accelerated filer        .


Non-accelerated filer          .

Smaller reporting company    X  .

(Do not check if a smaller reporting company)


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes       .  No   X  .


Applicable only to issuers involved in bankruptcy proceedings during the preceding five years:


Indicate by check mark whether the registrant filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.   Yes        .  No        .


Applicable only to corporate issuers:


Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.  As of August 7, 2012, there were 370,500,750 shares of common stock, $0.001 par value, issued and outstanding.





EXPLANATORY NOTE


We are filing this Amendment No. 2 to our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2012, filed with the Securities and Exchange Commission on August 14, 2012 (the “Form 10-Q”), to amend and restate in its entirety, Item 1 “Legal Proceedings” of Part II.  No other changes have been made to the Form 10-Q.



2






PART II – OTHER INFORMATION


ITEM 1

Legal Proceedings


On May 1, 2012, we filed a complaint against Deal Flow Media, Inc., et al. in the Circuit Court for Montgomery County, Maryland. In the complaint, we allege a series of false, defamatory and malicious statements were published by the Defendants in an attempt to cause harm to the Company.  The basis of our claims relate to what we believe was a deliberate campaign by Deal Flow to cause serious injury to our reputation and business interests, including, spreading false and defamatory information to our actual and prospective business partners, and announcing international business deals with companies that did not exist.  Deal Flow disseminated this false and defamatory information about the company in emails, articles, and telephone calls that we believe were received and understood by some of our business partners and others to mean that we were engaged in illegal activity and were not a legitimate company.  Our complaint seeks $2,000,000.00 in damages in addition to statutory damages, punitive damages, attorneys’ fees and costs, and such other relief as the court deems proper.


In the ordinary course of business, we are from time to time involved in various pending or threatened legal actions.  The litigation process is inherently uncertain and it is possible that the resolution of such matters might have a material adverse effect upon our financial condition and/or results of operations.  However, in the opinion of our management, other than as set forth herein, matters currently pending or threatened against us are not expected to have a material adverse effect on our financial position or results of operations.



3






ITEM 6

Exhibits


(a)

Exhibits


3.1 (1)

 

Articles of Incorporation of Sunpeaks Ventures, Inc.

 

 

 

3.2 (2)

 

Amended and Restated Articles of Incorporation of Sunpeaks Ventures, Inc.

 

 

 

3.3 (1)

 

Bylaws of Sunpeaks Ventures, Inc.

 

 

 

10.1 (3)

 

Settlement Agreement with Scott Beaudette dated February 13, 2012

 

 

 

10.2 (3)

 

Share Exchange Agreement with HDS

 

 

 

10.3 (3)

 

Management Agreement with Mackie Barch

 

 

 

10.4 (3)

 

Lease Agreement

 

 

 

10.5 (4)

 

Settlement Agreement with Whetu, Inc. dated February 13, 2012

 

 

 

10.6 (4)

 

Promissory Note with Eagle Bank for $200,000 dated August 4, 2011

 

 

 

10.7 (4)

 

Amended and Restated Acquisition Agreement with Global Nutritional Research, LLC dated July 2011

 

 

 

10.8 (4)

 

Agreement between Global Nutritional Research , LLC and National Community Pharmacists Association (NCPA) dated April 27, 2010

 

 

 

10.9 (4)

 

Business Proposal between Global Nutritional Research, LLC and Safe Chain Solutions

 

 

 

10.10 (5)

 

Paul Silas Endorsement Agreement, dated March 8, 2012.

 

 

 

10.11 (7)

 

Sunpeaks Ventures, Inc. Convertible Promissory Note issued to Lysander Overseas, Inc. dated April 5, 2012

 

 

 

10.12 (6)

 

First Amendment to Sunpeaks Ventures, Inc. Convertible Promissory Note to Lysander Overseas, Inc. dated May 10, 2012

 

 

 

10.13 (7)

 

Pass-Through Sponsorship Letter Agreement with TrailBlazers, Inc. dated April 5, 2012

 

 

 

10.14 (7)

 

Binding Letter of Commitment with Philadelphia Soul dated April 24, 2012

 

 

 

10.15 (7)

 

Advertising and Promotion Agreement with New Cardinals Stadium, LLC and Arizona Football Club, LLC dated April 11, 2012

 

 

 

10.16 (7)

 

Binding Letter of Commitment with Sovereign Talent Group, Inc. dated April 19, 2012

 

 

 

10.17 (7)

 

Binding Letter of Commitment with Dayton Professional Baseball Club, LLC dated April 18, 2012

 

 

 

10.18 (7)

 

Agreement with CBS Radio, Inc. dated April 26, 2012

 

 

 

10.19 (7)

 

Agreement with Pulse Advertising, LLC dated May 2, 2012

 

 

 

10.20 (7)

 

Marketing and Sponsorship Agreement with Hurricane Sports Properties, LLC dated May 1, 2012

 

 

 

31.1

 

Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer

 

 

 

31.2

 

Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer

 

 

 

32.1

 

Chief Executive Officer Certification Pursuant to 18 USC, Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.



4






 

 

 

32.2

 

Chief Financial Officer Certification Pursuant to 18 USC, Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

100.INS

 

XBRL Instance Document

100.SCH

 

XBRL Schema Document

100.CAL

 

XBRL Calculation Linkbase Document

100.DEF

 

XBRL Definition Linkbase Document

100.LAB

 

XBRL Lables Linkbase Document

100.PRE

 

XBRL Presentation Linkbase Document


(1)

Incorporated by reference from our Registration Statement on Form S-1, filed with the Commission on September 18, 2009.


(2)

Incorporated by reference from our Current Report on Form 8-K filed with the Commission on November 4, 2011.


(3)

Incorporated by reference from our Current Report on Form 8-K filed with the Commission on February 17, 2012.


(4)

Incorporated by reference from our Amended Current Report on Form 8-K/A filed with the Commission on July 27, 2012.


(5)

Incorporated by reference from our Amended Current Report on Form 8-K/A filed with the Commission on August 3, 2012.


(6)

Incorporated by reference from our Current Report on Form 8-K filed with the Commission on May 16, 2012


(7)

Incorporated by reference from our Quarterly Report on Form 10-Q for the period ended June 30, 2012 filed with the Commission on August 14, 2012.



SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



 

Sunpeaks Ventures, Inc.

 

 

 

 

Dated:  October 25, 2012

/s/ Mackie Barch

 

By:

Mackie Barch

 

Its:

President and Chief Executive Officer

 

 







5